Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Chamblee, GA 30341, USA.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Public Health Nutr. 2021 Aug;24(12):3791-3796. doi: 10.1017/S1368980021002019. Epub 2021 May 11.
Population reductions in Na intake could prevent hypertension, and current guidelines recommend that clinicians advise patients to reduce intake. This study aimed to estimate the prevalence of taking action and receiving advice from a health professional to reduce Na intake in ten US jurisdictions, including the first-ever data in New York state and Guam.
Weighted prevalence and 95 % CI overall and by location, demographic group, health status and receipt of provider advice using self-reported data from the 2017 Behavioral Risk Factor Surveillance System optional Na module.
Seven states, the District of Columbia, Puerto Rico and Guam.
Adults aged ≥ 18 years.
Overall, 53·6 % (95 % CI 52·7, 54·5) of adults reported taking action to reduce Na intake, including 54·8 % (95 % CI 52·8, 56·7) in New York and 61·2 % (95 % CI 57·6, 64·7) in Guam. Prevalence varied by demographic and health characteristic and was higher among adults who reported having hypertension (72·5 %; 95 % CI 71·2, 73·7) v. those who did not report having hypertension (43·9 %; 95 % CI 42·7, 45·0). Among those who reported receiving Na reduction advice from a health professional, 82·6 % (95 % CI 81·3, 83·9) reported action v. 44·4 % (95 % CI 43·4, 45·5) among those who did not receive advice. However, only 24·0 % (95 % CI 23·3, 24·7) of adults reported receiving advice from a health professional to reduce Na intake.
The majority of adults report taking action to reduce Na intake. Results highlight an opportunity to increase Na reduction advice from health professionals during clinical visits to better align with existing guidelines.
降低钠摄入量可能有助于预防高血压，当前的指南建议临床医生建议患者减少钠的摄入量。本研究旨在评估美国十个司法管辖区采取行动和接受健康专业人员减少钠摄入量建议的流行率，包括纽约州和关岛的首次数据。
使用 2017 年行为风险因素监测系统（BRFSS）中钠模块的自我报告数据，按地点、人口统计学组、健康状况和收到提供者建议的情况，对总体和每个地点的加权流行率及 95%置信区间进行估计。
七个州、哥伦比亚特区、波多黎各和关岛。
年龄≥18 岁的成年人。
总体而言，53.6%（95%CI 52.7,54.5）的成年人报告采取了减少钠摄入量的行动，包括纽约州的 54.8%（95%CI 52.8,56.7）和关岛的 61.2%（95%CI 57.6,64.7）。流行率因人口统计学和健康特征而异，且在报告患有高血压的成年人中更高（72.5%；95%CI 71.2,73.7），而在未报告患有高血压的成年人中更低（43.9%；95%CI 42.7,45.0）。在报告从健康专业人员那里获得减少钠摄入量建议的人群中，82.6%（95%CI 81.3,83.9）报告了行动，而在未获得建议的人群中，这一比例为 44.4%（95%CI 43.4,45.5）。然而，只有 24.0%（95%CI 23.3,24.7）的成年人报告从健康专业人员那里获得了减少钠摄入量的建议。
大多数成年人都在采取行动减少钠的摄入量。结果突出了一个机会，即在临床就诊期间增加健康专业人员提供的钠减少建议，以更好地与现有指南保持一致。
